Foghorn Therapeutics Inc.

NASDAQ:FHTX

8.85 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q1
Omzet 7.8086.8885.055.76917.4785.5995.3094.1846.6344.493.920.7130.0410.2790.2860.2510.17900000000
Kosten van de omzet 0.70.80.8350.8520.8642.1662.0590.0191.10225.9741.9251.920.49418.64218.72616.47116.11313.62811.50313.5211.2920000
Brutowinst 7.1086.0884.2154.91716.6143.4333.254.1655.532-21.4841.995-1.187-20.453-18.363-18.44-16.22-15.934-13.628-11.503-13.52-11.2920000
Brutowinstmarge 0.910.8840.8350.8520.9510.6130.6120.9950.834-4.7850.509-1.665-498.854-65.817-64.476-64.622-89.01700000000
Onderzoek- en ontwikkelingskosten 23.98922.99724.69923.35326.25129.24829.98528.20826.92825.97424.50822.46320.49418.64218.72616.47116.11313.62811.50313.5211.2929.7759.7755.3065.306
Algemene en administratieve kosten 6.9717.3257.717.0228.3088.4018.6417.8627.9657.7047.2166.3325.8084.8984.694.5592.5551.9112.2211.6661.8081.6241.6241.2061.206
Verkoop- en marketingkosten 0000000000000000000000000
Verkoop-, algemene en administratieve kosten 6.9717.3257.717.0228.3088.4018.6417.8627.9657.7047.216-15.3745.8084.8984.694.5592.5551.9112.2211.6661.8081.6241.6241.2061.206
Overige kosten 00.7830.7390.6780.7210.7123.38900000000-7.1030000000-13.025-13.025
Bedrijfskosten 31.6630.32232.40930.37534.55937.64938.62636.0734.89333.67831.724-73.15626.30223.5423.416-18.59918.66815.53913.72415.18613.111.39911.399-6.512-6.512
Bedrijfsresultaat -23.852-24.234-28.194-25.458-17.081-32.05-33.317-31.886-28.259-29.188-27.804-28.082-26.261-23.261-23.13-20.779-18.489-15.539-13.724-15.186-13.1-11.399-11.399-6.512-6.512
Bedrijfsresultaat ratio -3.055-3.518-5.583-4.413-0.977-5.724-6.276-7.621-4.26-6.501-7.093-39.386-640.512-83.373-80.874-82.785-103.29100000000
Totaal overige inkomsten en kosten netto 4.733.6533.1783.3383.4743.5053.38932.491.8750.89-1.0610.1810.150.1440.0210.122-0.184-0.228-0.1060.0080.0270.027-0.072-0.072
Inkomen voor belasting -19.122-22.979-25.016-22.12-13.607-28.545-29.928-28.886-25.769-27.313-26.91472.076-26.08-23.111-22.986-0.069-18.367-15.723-13.952-15.292-13.092-11.372-11.372-6.584-6.584
Inkomen voor belasting ratio -2.449-3.336-4.954-3.834-0.779-5.098-5.637-6.904-3.884-6.083-6.866101.088-636.098-82.835-80.371-0.274-102.60900000000
Belastingkosten -0.700.7921.9860.7380.9420.565.247-2.491.875-0.89-98.6760.680.6450.6320.50918.3490.0140.2580.0720.121000.0210.021
Nettowinst -19.122-22.979-25.016-24.106-14.345-29.487-30.488-34.133-23.279-27.313-26.024170.751-26.08-23.111-22.986-0.069-18.367-15.723-13.952-15.292-13.092-11.372-11.372-6.584-6.584
Nettowinstmarge -2.449-3.336-4.954-4.179-0.821-5.266-5.743-8.158-3.509-6.083-6.639239.483-636.098-82.835-80.371-0.274-102.60900000000
WPA (Winst Per Aandeel) -0.31-0.45-0.59-0.57-0.34-0.7-0.73-0.82-0.56-0.66-0.634.62-0.71-0.63-0.62-0.004-0.51-0.71-0.63-0.69-0.59-2.95-2.95-0.34-0.34
Verwaterde WPA -0.31-0.45-0.59-0.57-0.34-0.7-0.73-0.82-0.56-0.66-0.634.62-0.71-0.63-0.62-0.004-0.51-0.71-0.63-0.69-0.59-2.95-2.95-0.34-0.34
EBITDA -18.422-23.443-27.359-24.606-16.217-31.174-32.458-25.968-27.416-28.369-26.993-26.817-24.72-21.832-21.728-20.216-17.91-15.285-13.469-14.881-12.809-11.254-11.254-6.397-6.397
EBITDA ratio -2.359-3.402-5.418-4.265-0.928-5.568-6.276-8.877-3.757-5.901-6.65999.01-602.927-78.251-75.9724.2121.32100000000